Subscribe to RSS
DOI: 10.1055/a-0584-9264
Update Augenheilkunde – Amblyopie und Refraktionsfehler
Amblyopia and refractive errorPublication History
Publication Date:
17 May 2018 (online)
![](https://www.thieme-connect.de/media/augenheilkunde-u2d/201802/lookinside/thumbnails/10-1055-a-0584-9264_au5849264_joachimsen-1.jpg)
Zusammenfassung
Der folgende Beitrag stellt zwei aktuelle Themen der Kinderophthalmologie in den Fokus, die vermutlich auch immer wieder in der kinder- und jugendärztlichen Praxis relevant sein werden: die Amblyopie und ihre Früherkennung inklusive Videorefraktometrie und Refraktionsfehler im Schulkindalter mit Fokus auf Myopie, deren Häufigkeit weltweit zunimmt
Abstract
Myopia is on the increase worldwide and will become a major challenge over the next decades in terms of secondary ophthalmologic complications. There are effective therapeutic options available to slow or prevent the progression of myopia. So far, it has not been investigated whether there are possible additive effects of these interventions. Further investigations – especially in Caucasian populations – are necessary to verify the study results available from Asia. There is limited data on how long further progression of myopia is preventable. A therapy appears reasonable as long as a progression of myopia is detectable.
Consistent childhood amblyopia screening provides a cost-effective measure for the prevention of visual disturbances over the course of life. How this can be best integrated into the existing system of “U-investigations”, must be clarified by the cost-bearers and professional associations. This discourse should be supported by close interdisciplinary exchange and further studies on the prevalence of different degrees of amblyopia. In addition, sensitive and specific or even multi-stage tests should be developed in order to implement an early detection that is cost-effective and saves resources.
-
Die Myopie nimmt weltweit zu und wird in den nächsten Jahrzehnten zu einer großen Herausforderung hinsichtlich ihrer sekundären ophthalmologischen Komplikationen.
-
Es sind effektive therapeutische Möglichkeiten verfügbar, um das Fortschreiten einer Myopie zu verlangsamen bzw. ihr Auftreten zu verhindern.
-
Bislang wurde noch nicht untersucht, ob es mögliche additive Effekte dieser Interventionen gibt.
-
Weiterführende Untersuchungen – gerade an kaukasischen Populationen – sind notwendig, um die Übertragbarkeit der aus Asien vorliegenden Studienergebnisse zu überprüfen.
-
Es liegen nur wenige Daten vor, wie lange gegen ein weiteres Fortschreiten einer Myopie behandelt werden soll. Eine Therapie erscheint so lange sinnvoll, wie eine Progression der Kurzsichtigkeit nachweisbar ist.
-
Ein konsequentes Amblyopie-Screening im Kindesalter bietet eine kosteneffektive Maßnahme zur Prävention von Sehstörungen im Verlauf des weiteren Lebens. Wie dieses am besten in das bestehende System der U-Untersuchungen integriert werden kann, muss durch die Kostenträger und Berufsverbände geklärt werden.
-
Unterstützt werden soll dieser Diskurs durch engen interdisziplinären Austausch und weiterführende Studien zur Prävalenz verschiedener Schweregrade von Amblyopie. Zudem sollen sensitive und spezifische oder sogar mehrstufige Tests erarbeitet werden, um eine kosteneffektive und ressourcensparende Früherkennung umzusetzen.
-
Literatur
- 1 Elflein HM. [Amblyopia. Epidemiology, causes and risk factors]. Ophthalmologe 2016; 113: 283-288
- 2 Elflein HM, Fresenius S, Lamparter J. et al. The prevalence of amblyopia in Germany: data from the prospective, population-based Gutenberg Health Study. Dtsch Arztebl Int 2015; 112: 338-344
- 3 van Leeuwen R, Eijkemans MJ, Vingerling JR. et al. Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study. Br J Ophthalmol 2007; 91: 1450-1451
- 4 Lagrèze WA. Vision screening in preschool children: do the data support universal screening?. Dtsch Arztebl Int 2010; 107: 495-499
- 5 Schnorbus U, Büchner TF, Grenzebach UH. et al. Prävalenz von amblyogenen Veränderungen bei Kindergartenkindern: Ergebnisse einer Reihenuntersuchung. Ophthalmologe 2002; 99: 114
- 6 Gräf MH, Rost D, Becker R. Influence of viewing distance on vertical strabismus. Graefes Arch Clin Exp Ophthalmol 2004; 242: 571-575
- 7 Gräf M. Früherkennung von Sehstörungen bei Kindern: Durchleuchtungstest nach Brückner – Ein Muss bei allen Vorsorgeuntersuchungen im Kindesalter. Dtsch Arztebl 2007; 104: 724-729
- 8 Iyer V, van Samkar A, Saeed P. The Bruckner test variant (BTV): a promising instrument in detecting vision disorders. Am Orthopt J 2013; 63: 97-102
- 9 Nathan NR, Donahue SP. Modification of Plusoptix referral criteria to enhance sensitivity and specificity during pediatric vision screening. J AAPOS 2011; 15: 551-555
- 10 Arthur BW, Riyaz R, Rodriguez S. et al. Field testing of the plusoptiX S04 photoscreener. J AAPOS 2009; 13: 51-57
- 11 Hered RW, Wood DL. Preschool vision screening in primary care pediatric practice. Public Health Rep 2013; 128: 189-197
- 12 Holden BA, Fricke TR, Wilson DA. et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016; 123: 1036-1042
- 13 Dolgin E. The myopia boom. Nature 2015; 519: 276-278
- 14 Williams KM, Verhoeven VJ, Cumberland P. et al. Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium. Eur J Epidemiol 2015; 30: 305-315
- 15 COMET Group. Myopia stabilization and associated factors among participants in the Correction of Myopia Evaluation Trial (COMET). Invest Ophthalmol Vis Sci 2013; 54: 7871-7884
- 16 Verhoeven VJ, Hysi PG, Wojciechowski R. et al. Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet 2013; 45: 314-318
- 17 McKnight CM, Sherwin JC, Yazar S. et al. Myopia in young adults is inversely related to an objective marker of ocular sun exposure: the Western Australian Raine cohort study. Am J Ophthalmol 2014; 158: 1079-1085
- 18 Mirshahi A, Ponto KA, Hoehn R. et al. Myopia and level of education: results from the Gutenberg Health Study. Ophthalmology 2014; 121: 2047-2052
- 19 Rose KA, Morgan IG, Ip J. et al. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology 2008; 115: 1279-1285
- 20 Lagrèze WA, Joachimsen L, Schaeffel F. Current recommendations for deceleration of myopia progression [article in German]. Ophthalmologe 2017; 114: 24-29
- 21 Brennan NA. Predicted reduction in high myopia for various degrees of myopia control. Cont Lens Anterior Eye 2012; 35: e14-e15
- 22 Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res 2012; 31: 622-660
- 23 French AN, Ashby RS, Morgan IG. et al. Time outdoors and the prevention of myopia. Exp Eye Res 2013; 114: 58-68
- 24 Jones LA, Sinnott LT, Mutti DO. et al. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci 2007; 48: 3524-3532
- 25 Sherwin JC, Reacher MH, Keogh RH. et al. The association between time spent outdoors and myopia in children and adolescents: a systematic review and meta-analysis. Ophthalmology 2012; 119: 2141-2151
- 26 Wu PC, Tsai CL, Wu HL. et al. Outdoor activity during class recess reduces myopia onset and progression in school children. Ophthalmology 2013; 120: 1080-1085
- 27 He M, Xiang F, Zeng Y. et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA 2015; 314: 1142-1148
- 28 Gwiazda J, Deng L, Manny R. et al. Seasonal variations in the progression of myopia in children enrolled in the correction of myopia evaluation trial. Invest Ophthalmol Vis Sci 2014; 55: 752-758
- 29 Derby H. On the atropine treatment of acquired and progressive myopia. Trans Am Ophthalmol Soc 1874; 2: 139-154
- 30 Huang J, Wen D, Wang Q. et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology 2016; 123: 697-708
- 31 Polling JR, Kok RG, Tideman JW. et al. Effectiveness study of atropine for progressive myopia in Europeans. Eye (Lond) 2016; 30: 998-1004
- 32 Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01 % eyedrops. Ophthalmology 2016; 123: 391-399
- 33 Loughman J, Flitcroft DI. The acceptability and visual impact of 0.01 % atropine in a Caucasian population. Br J Ophthalmol 2016; 100: 1525-1529
- 34 Cooper J, Eisenberg N, Schulman E. et al. Maximum atropine dose without clinical signs or symptoms. Optom Vis Sci 2013; 90: 1467-1472
- 35 Mutti DO, Hayes JR, Mitchell GL. et al. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci 2007; 48: 2510-2519
- 36 Smith EL. Optical treatment strategies to slow myopia progression: effects of the visual extent of the optical treatment zone. Exp Eye Res 2013; 114: 77-88
- 37 Anstice NS, Phillips JR. Effect of dual-focus soft contact lens wear on axial myopia progression in children. Ophthalmology 2011; 118: 1152-1161
- 38 Lam CS, Tang WC, Tse DY. et al. Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial. Br J Ophthalmol 2014; 98: 40-45
- 39 Katz J, Schein OD, Levy B. et al. A randomized trial of rigid gas permeable contact lenses to reduce progression of childrenʼs myopia. Am J Ophthalmol 2003; 136: 82-90